Sensus Healthcare, Inc. Selling, General and Administrative Expense
Sensus Healthcare, Inc. (SRTS) reported Selling, General and Administrative Expense of $1.79 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-14
- Sensus Healthcare, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $1.79M, a 10.07% decline year-over-year.
- Sensus Healthcare, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $2.04M, a 7.47% decline year-over-year.
- Sensus Healthcare, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $1.76M, a 27.07% decline year-over-year.
- Sensus Healthcare, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $1.92M, a 21.87% increase year-over-year.
- Sensus Healthcare, Inc. selling, general and administrative expense for fiscal 2025 was $7.87M, a 10.16% increase from fiscal 2024.
- Sensus Healthcare, Inc. selling, general and administrative expense for fiscal 2024 was $7.15M, a 38.62% increase from fiscal 2023.
- Sensus Healthcare, Inc. selling, general and administrative expense for fiscal 2023 was $5.16M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.79M 10-Q · filed 2026-08-14 | $3.83M 10-Q · filed 2026-08-14 | $5.59M derived: sum of 3 quarters · filed 2026-08-14 | $7.51M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $2.04M 10-Q · filed 2026-05-13 | $3.81M derived: sum of 2 quarters · filed 2026-05-13 | $5.72M derived: sum of 3 quarters · filed 2026-05-13 | $7.71M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $3.68M derived: sum of 2 quarters · filed 2026-03-04 | $5.67M derived: sum of 3 quarters · filed 2026-08-14 | $7.87M 10-K · filed 2026-03-04 |
| 2025-09-30 | $1.92M 10-Q · filed 2025-11-12 | $3.90M derived: sum of 2 quarters · filed 2026-08-14 | $6.11M 10-Q · filed 2025-11-12 | $8.53M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $1.99M 10-Q · filed 2026-08-14 | $4.19M 10-Q · filed 2026-08-14 | $6.61M derived: sum of 3 quarters · filed 2026-08-14 | $8.18M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $2.21M 10-Q · filed 2026-05-13 | $4.62M derived: sum of 2 quarters · filed 2026-05-13 | $6.20M derived: sum of 3 quarters · filed 2026-05-13 | $7.78M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $3.99M derived: sum of 2 quarters · filed 2026-03-04 | $5.57M derived: sum of 3 quarters · filed 2026-03-04 | $7.15M 10-K · filed 2026-03-04 |
| 2024-09-30 | $1.57M 10-Q · filed 2025-11-12 | $3.15M derived: sum of 2 quarters · filed 2025-11-12 | $4.73M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $1.58M 10-Q · filed 2025-08-12 | $3.16M 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $1.58M 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $5.16M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |